Drug lookup
Drug reference

pentoxiphylline

Phosphodiesterase inhibitor, Rheologic agent · Peripheral vasodilator

Phosphodiesterase inhibitor, Rheologic agentPeripheral vasodilator
CDSCO approved
EXCRETION
not curated
INTERACTIONS
none in our sources
PREGNANCY
not curated

Mechanism

Weak phosphodiesterase (PDE) inhibitor. Increases blood flow in ischaemic areas by reducing whole blood viscosity and by improving flexibility of RBCs (rheological action).

Indications

Intermittent claudication (due to occlusive vascular disease like Buerger’s disease)Trophic leg ulcersTransient ischaemic attacks (TIAs)Nonhaemorrhagic strokeChronic cerebrovascular insufficiency

Dosing

Adult
400 mg BD–TDS

Side effects

Common
nauseavomitingdyspepsiabloating

Related guidelines

Ask House about pentoxiphylline

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: KD Tripathi 7e·Verified: 2026-05-10 · House clinical team